A study was conducted to monitor EFT's mechanism of action in the central nervous system physically and psychological symptoms.
Measurements including Heart rate variability and heart coherence, measuring resting heart rate and blood pressure measurements to test the circulatory system, the endocrine system was monitored for cortisol and immune function using saliva measurements. 203 participants in a 4 day training workshop held in different locations. At one workshop the participants also had comprehensive physiological testing.
The meat of the study is within the following numbers:
40% declines in anxiety.
35% decline in depression.
32% PTSD decline.
57% decline in pain.
74% decline in cravings.
Increase in feelings of happiness by 31%.
113% increase in immune function.
8% decrease in resting heart rate.
37% decrease in cortisol (the stress hormone.)
6% decrease in Systolic blood pressure and 8% decrease in Diastolic blood pressure.
Heart rate variability and heart coherence had positive trends that were observed for HRV and HC and gains were maintained on follow-up, indicating EFT results in positive health effects as well as increased mental well-being.
When measured against the standards of the American Psychological Association’s Division 12 Task Force on Empirically Validated Treatments, EFT is found to be an “evidence-based” practice for anxiety, depression, phobias, and posttraumatic stress disorder (PTSD) .
Anxiety/Depression:
EFT has been extensively investigated for anxiety and depression. In the first large-scale study of 5000 patients seeking treatment for anxiety across 11 clinics over a 5.5-year period, patients received either traditional anxiety treatment in the form of cognitive behavioral therapy (CBT), with medication if needed, or acupoint tapping with no medication.26 An improvement was found in 90% of patients who received acupoint tapping therapy compared to 63% of the CBT participants. Only 3 acupoint tapping sessions were needed before an individual’s anxiety reduced, while an average of 15 was needed for CBT to show results. Complete relief of symptoms was seen in 76% of people in the acupoint taping group compared with 51% of people in the CBT group. One year later, the improvements seen were maintained by 78% of the acupoint group compared with 69% of the CBT group. Other studies also indicate equivalence or superiority to CBT
A meta-analysis of EFT for depression examined 20 studies.31 These included 8 outcome studies (n = 461) as well as 12 randomized controlled trials (n = 398). EFT demonstrated a very large effect size in the treatment of depression. Cohen’s d across all studies was 1.31, with little difference between randomized controlled trials and uncontrolled outcome studies. Effect sizes at posttest, less than 90 days, and greater than 90 days were 1.31, 1.21, and 1.11, respectively, indicating durable maintenance of participant gains. EFT was more efficacious than physical interventions such as diaphragmatic breathing and as well as psychological interventions such as supportive interviews.31
The health care workers study also found a significant reduction in depression after EFT.18 A randomized controlled trial with a population of 59 veterans successfully treated for PTSD also identified a significant reduction in depressive symptoms after six 1-hour EFT sessions.32 Church et al6 reported that after brief group intervention using EFT for depression in 18 college students, those who received EFT were found to have significantly less depression than those who did not receive it, with an average depression score in the “nondepressed range” following treatment, compared to the control group who demonstrated no change in depressive symptoms. More recent research comparing EFT to CBT for 10 patients diagnosed with major depressive disorder, found after 8 weeks of group treatment (16 hours), both interventions produced significant reductions in depressive symptoms. The CBT group indicated a significant reduction postintervention, but this was not maintained over time. The EFT group however, showed a delayed effect of significant reductions in symptoms at 3- and 6-month follow-ups.
Coming SOON!
Coming SOON!
Copyright © 2024 Tap Into Creativity - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.